​

Funding Round

Venture Round - Sparrow Pharmaceuticals

Venture Round - Sparrow Pharmaceuticals

Investment Firm

Overview

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Announced Date

Apr 24, 2024

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

OrbiMed

OrbiMed

OrbiMed is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorOrbiMed
Participant InvestorRiverVest
Participant InvestorU.S. Venture Partners

Round Details and Background

Sparrow Pharmaceuticals raised $10200000 on 2024-04-24 in Venture Round

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 13, 2021
Venture Round - Sparrow Pharmaceuticals
-1.1M
May 18, 2021
Series A - Sparrow Pharmaceuticals
3-50.0M
Apr 24, 2024
Venture Round - Sparrow Pharmaceuticals
3-10.2M

Recent Activity

There is no recent news or activity for this profile.